DURHAM, N.C., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, announced that Jeff Wolf, Heat’s Chief Executive Officer, will deliver a corporate presentation at the 8th Annual Biotech Showcase™, being held January 11-13, 2016 in San Francisco, CA.
8th Annual Biotech Showcase™
Date: Wednesday, January 13, 2016
Time: 11:30 a.m. Pacific Time
Location: Parc 55 San Francisco Union Square Hotel – Room: Mission II (4th Floor)
Links to a live audio webcast and replay of the presentation may be accessed on Heat Biologics’ website at http://ir.heatbio.com/events-presentations.
About Heat Biologics, Inc.
Heat Biologics, Inc. (Nasdaq:HTBX) is an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer. Heat’s highly specific T cell-stimulating platform technologies, ImPACT and ComPACT, form the basis of its product candidates. These platforms, in combination with other therapies, such as checkpoint inhibitors, are designed to address three distinct but synergistic mechanisms of action: robust activation of CD8+ “killer” T cells (one of the human immune system’s most potent weapons against cancer); T cell co-stimulation to further enhance patients’ immune response; and reversal of tumor-induced immune suppression. Currently, Heat is conducting a Phase 2 trial with its HS-410 (vesigenurtacel-L) in patients with non-muscle invasive bladder cancer (NMIBC) and a Phase 1b trial with its HS-110 (viagenpumatucel-L) in combination with an anti-PD-1 checkpoint inhibitor to treat patients with non-small cell lung cancer (NSCLC). For more information, please visit www.heatbio.com.
CONTACT: Heat Biologics, Inc. Jennifer Almond Investor and Media Relations 919-240-7133 [email protected]


Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Shell M&A Chief Exits After BP Takeover Proposal Rejected
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 



